Edition:
United Kingdom

Aquestive Therapeutics Inc (AQST.OQ)

AQST.OQ on NASDAQ Stock Exchange Global Market

7.39USD
14 Dec 2018
Change (% chg)

$-0.59 (-7.39%)
Prev Close
$7.98
Open
$7.95
Day's High
$7.98
Day's Low
$7.38
Volume
22,013
Avg. Vol
37,555
52-wk High
$19.80
52-wk Low
$7.38

Latest Key Developments (Source: Significant Developments)

Aquestive Therapeutics Launches Sympazan Oral Film With Widespread U.S. Availability
Thursday, 29 Nov 2018 

Nov 29 (Reuters) - Aquestive Therapeutics Inc ::AQUESTIVE THERAPEUTICS LAUNCHES SYMPAZAN™ (CLOBAZAM) ORAL FILM WITH WIDESPREAD U.S. AVAILABILITY.  Full Article

Aquestive Therapeutics Gets Tentative FDA Approval For Sympazan (Clobazam) Oral Film
Friday, 31 Aug 2018 

Aug 31 (Reuters) - Aquestive Therapeutics Inc ::AQUESTIVE THERAPEUTICS ANNOUNCES TENTATIVE FDA APPROVAL FOR SYMPAZAN (CLOBAZAM) ORAL FILM.SAYS FINAL FDA APPROVAL FOR SYMPAZAN PENDING EXPIRATION OF ORPHAN DRUG EXCLUSIVITY PERIOD FOR ONFI, EXPECTED IN OCT.  Full Article

FDA declines to approve Aquestive's Viagra rival

Nov 16 Aquestive Therapeutics Inc said on Friday the U.S. Food and Drug Administration declined to approve its erectile dysfunction treatment and sought additional data.